| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sterol O-acyltransferase activity | 5.88e-05 | 3 | 89 | 2 | GO:0004772 | |
| GeneOntologyMolecularFunction | cholesterol O-acyltransferase activity | 5.88e-05 | 3 | 89 | 2 | GO:0034736 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 5.88e-05 | 3 | 89 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA binding | 1.24e-04 | 22 | 89 | 3 | GO:0000062 | |
| GeneOntologyMolecularFunction | fatty acid derivative binding | 1.62e-04 | 24 | 89 | 3 | GO:1901567 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 1.95e-04 | 5 | 89 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 2.07e-04 | 26 | 89 | 3 | GO:0120227 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGEF7 RASA4 PPP1R15B RGCC PHACTR4 MOB3B RASA4B SMO AJUBA FAM20A ATP2A3 PREX1 CCNA2 PLCE1 RGPD5 PHACTR1 | 4.84e-04 | 1418 | 89 | 16 | GO:0030234 |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 6.45e-04 | 38 | 89 | 3 | GO:0043015 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RASA4 RGCC PHACTR4 MOB3B RASA4B AJUBA FAM20A ATP2A3 PREX1 RGPD5 | 6.73e-04 | 656 | 89 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 1.06e-03 | 259 | 89 | 6 | GO:0019887 | |
| GeneOntologyMolecularFunction | ligase activity | 1.09e-03 | 174 | 89 | 5 | GO:0016874 | |
| Domain | Sterol_acyltranf_meta | 2.30e-05 | 2 | 90 | 2 | IPR030687 | |
| Domain | PHOSPHORYLASE | 6.87e-05 | 3 | 90 | 2 | PS00102 | |
| Domain | Phosphorylase | 6.87e-05 | 3 | 90 | 2 | PF00343 | |
| Domain | Glycg_phsphrylas | 6.87e-05 | 3 | 90 | 2 | IPR011833 | |
| Domain | - | 6.87e-05 | 3 | 90 | 2 | 4.10.1130.10 | |
| Domain | Glyco_trans_35 | 6.87e-05 | 3 | 90 | 2 | IPR000811 | |
| Domain | Oat_ACAT_DAG_ARE | 6.87e-05 | 3 | 90 | 2 | IPR014371 | |
| Domain | GCP | 2.27e-04 | 5 | 90 | 2 | IPR007259 | |
| Domain | Spc97_Spc98 | 2.27e-04 | 5 | 90 | 2 | PF04130 | |
| Domain | RPEL | 4.75e-04 | 7 | 90 | 2 | PS51073 | |
| Domain | RPEL | 4.75e-04 | 7 | 90 | 2 | PF02755 | |
| Domain | RPEL | 4.75e-04 | 7 | 90 | 2 | SM00707 | |
| Domain | RPEL_repeat | 4.75e-04 | 7 | 90 | 2 | IPR004018 | |
| Domain | BTK | 8.09e-04 | 9 | 90 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 8.09e-04 | 9 | 90 | 2 | IPR001562 | |
| Domain | SynN | 8.09e-04 | 9 | 90 | 2 | SM00503 | |
| Domain | BTK | 8.09e-04 | 9 | 90 | 2 | PF00779 | |
| Domain | ZF_BTK | 8.09e-04 | 9 | 90 | 2 | PS51113 | |
| Domain | t-SNARE | 1.16e-03 | 43 | 90 | 3 | IPR010989 | |
| Domain | Syntaxin | 1.23e-03 | 11 | 90 | 2 | PF00804 | |
| Domain | MBOAT_fam | 1.23e-03 | 11 | 90 | 2 | IPR004299 | |
| Domain | MBOAT | 1.23e-03 | 11 | 90 | 2 | PF03062 | |
| Domain | Syntaxin_N | 1.47e-03 | 12 | 90 | 2 | IPR006011 | |
| Domain | RasGAP | 2.01e-03 | 14 | 90 | 2 | SM00323 | |
| Domain | RasGAP_CS | 2.01e-03 | 14 | 90 | 2 | IPR023152 | |
| Domain | RasGAP | 2.31e-03 | 15 | 90 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.31e-03 | 15 | 90 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.31e-03 | 15 | 90 | 2 | PS50018 | |
| Domain | - | 2.64e-03 | 16 | 90 | 2 | 1.10.506.10 | |
| Domain | Syntaxin/epimorphin_CS | 2.64e-03 | 16 | 90 | 2 | IPR006012 | |
| Domain | SYNTAXIN | 2.64e-03 | 16 | 90 | 2 | PS00914 | |
| Domain | RasGAP_dom | 3.34e-03 | 18 | 90 | 2 | IPR001936 | |
| Domain | C2 | 3.71e-03 | 131 | 90 | 4 | PF00168 | |
| Domain | C2 | 4.35e-03 | 137 | 90 | 4 | SM00239 | |
| Domain | SNARE | 4.54e-03 | 21 | 90 | 2 | PF05739 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TUBGCP6 NBAS CRNKL1 SF3B3 DHX38 COPB2 SMC6 ASS1 EIF3E LAMB1 PYGM RAI14 POGZ TUBGCP2 MOV10 CCNA2 CREB3L2 RGPD5 | 8.39e-10 | 1155 | 90 | 18 | 20360068 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | HDAC3 NCAPG SF3B3 ARHGEF7 IARS1 NAE1 DHX38 COPB2 EIF3E MOB3B PYGM RAI14 KIF5C LBR ATP2A3 PREX1 TNPO3 MOV10 | 4.41e-09 | 1284 | 90 | 18 | 17353931 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | BLVRA CRNKL1 TMEM201 NCAPG SF3B3 IARS1 DHX38 COPB2 ASS1 EIF3E PYGB UTP20 RAI14 POGZ LBR USP3 MOV10 | 6.17e-08 | 1353 | 90 | 17 | 29467282 |
| Pubmed | A genome-wide association study of carotid atherosclerosis in HIV-infected men. | 5.82e-07 | 7 | 90 | 3 | 20009918 | |
| Pubmed | BLVRA HDAC3 CRNKL1 NCAPG SF3B3 NAE1 DHX38 COPB2 SMC6 ASS1 PYGB THOC5 CCNA2 | 2.10e-06 | 1014 | 90 | 13 | 32416067 | |
| Pubmed | 2.89e-06 | 38 | 90 | 4 | 27141870 | ||
| Pubmed | BLVRA NBAS NCAPG SF3B3 COPB2 EIF3E LAMB1 GCDH LBR TUBGCP2 TNPO3 SOAT1 MOV10 SLC27A2 CCNA2 | 4.14e-06 | 1440 | 90 | 15 | 30833792 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15992359 | ||
| Pubmed | Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. | 6.62e-06 | 2 | 90 | 2 | 26982734 | |
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 6.62e-06 | 2 | 90 | 2 | 11448776 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16647063 | ||
| Pubmed | Organization of human ACAT-2 gene and its cell-type-specific promoter activity. | 6.62e-06 | 2 | 90 | 2 | 11401500 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18000807 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18586678 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18269457 | ||
| Pubmed | Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. | 6.62e-06 | 2 | 90 | 2 | 22811412 | |
| Pubmed | Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. | 6.62e-06 | 2 | 90 | 2 | 14729857 | |
| Pubmed | P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments. | 6.62e-06 | 2 | 90 | 2 | 23382862 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25130497 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16041389 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15158756 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16230498 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23760262 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 7.12e-06 | 272 | 90 | 7 | 25315684 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | TMEM201 PDGFRB LOX IARS1 TM9SF4 SMC6 EIF3E POGZ LBR FUT8 USP3 TNPO3 SOAT1 | 1.32e-05 | 1203 | 90 | 13 | 29180619 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.45e-05 | 704 | 90 | 10 | 29955894 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CRNKL1 TMEM201 NCAPG SF3B3 PDGFRB IARS1 DHX38 COPB2 SMC6 EIF3E UTP20 POGZ LBR SOAT1 | 1.73e-05 | 1425 | 90 | 14 | 30948266 |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 9756920 | ||
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 1.98e-05 | 3 | 90 | 2 | 25637021 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 31900278 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CRNKL1 SF3B3 IARS1 DHX38 ASS1 EIF3E HELZ2 UTP20 RAI14 TUBGCP2 AJUBA THOC5 MOV10 | 2.10e-05 | 1257 | 90 | 13 | 36526897 |
| Pubmed | Functional consequences of necdin nucleocytoplasmic localization. | 2.37e-05 | 64 | 90 | 4 | 22442722 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HDAC3 TMEM201 SF3B3 ACTR5 DHX38 UTP20 POGZ LBR USP3 THOC5 SOAT1 SLC27A2 CREB3L2 | 2.83e-05 | 1294 | 90 | 13 | 30804502 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TMEM201 SNX4 NCAPG IARS1 COPB2 UTP20 GCDH LBR TUBGCP2 FUT8 TNPO3 | 3.22e-05 | 942 | 90 | 11 | 31073040 |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 21460216 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 22669916 | ||
| Pubmed | Cellular pregnenolone esterification by acyl-CoA:cholesterol acyltransferase. | 3.96e-05 | 4 | 90 | 2 | 22474282 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 20133765 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 15308631 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 16234249 | ||
| Pubmed | Analysis of a lung defect in autophagy-deficient mouse strains. | 4.17e-05 | 26 | 90 | 3 | 24275123 | |
| Pubmed | 4.19e-05 | 638 | 90 | 9 | 33239621 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 4.67e-05 | 647 | 90 | 9 | 26618866 | |
| Pubmed | TUBGCP6 NBAS NCAPG PDGFRB IARS1 DHX38 EIF3E HELZ2 PYGB LBR TUBGCP2 FUT8 | 4.77e-05 | 1168 | 90 | 12 | 19946888 | |
| Pubmed | 5.01e-05 | 653 | 90 | 9 | 22586326 | ||
| Pubmed | 5.25e-05 | 657 | 90 | 9 | 36180527 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM201 P3H2 LOX TM9SF4 NAE1 LAMB1 UTP20 LBR FUT8 ATP2A3 SOAT1 CREB3L2 | 6.23e-05 | 1201 | 90 | 12 | 35696571 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 6.33e-05 | 262 | 90 | 6 | 36880596 | |
| Pubmed | GCP5 and GCP6: two new members of the human gamma-tubulin complex. | 6.59e-05 | 5 | 90 | 2 | 11694571 | |
| Pubmed | Two conserved domains in PCIF1 mediate interaction with pancreatic transcription factor PDX-1. | 6.59e-05 | 5 | 90 | 2 | 17126328 | |
| Pubmed | Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase. | 6.59e-05 | 5 | 90 | 2 | 12077311 | |
| Pubmed | HDAC3 CRNKL1 THOP1 SF3B3 IARS1 COPB2 ASS1 EIF3E LAMB1 RAI14 LBR THOC5 | 8.90e-05 | 1247 | 90 | 12 | 27684187 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | BLVRA CRNKL1 THOP1 SF3B3 AEBP1 PDGFRB LOX COPB2 ASS1 LAMB1 LBR FUT8 NARS2 | 9.09e-05 | 1451 | 90 | 13 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NCAPG THOP1 IARS1 NAE1 DHX38 PHACTR4 COPB2 ASS1 EIF3E LAMB1 PYGB NUDCD1 TNPO3 | 9.34e-05 | 1455 | 90 | 13 | 22863883 |
| Pubmed | Synaptotagmin VI and VIII and syntaxin 2 are essential for the mouse sperm acrosome reaction. | 9.87e-05 | 6 | 90 | 2 | 15774481 | |
| Pubmed | The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. | 9.87e-05 | 6 | 90 | 2 | 25915022 | |
| Pubmed | Hedgehog actively maintains adult lung quiescence and regulates repair and regeneration. | 9.87e-05 | 6 | 90 | 2 | 26436454 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 9.90e-05 | 714 | 90 | 9 | 28302793 | |
| Pubmed | TUBGCP6 NBAS TMEM201 NCAPG SF3B3 TBC1D31 NAE1 PPP1R15B PHACTR4 LAMB1 LBR THOC5 SOAT1 | 1.16e-04 | 1487 | 90 | 13 | 33957083 | |
| Pubmed | CRNKL1 THOP1 PDE9A PDGFRB PEG3 LAMB1 RAI14 POGZ KIF5C FUT8 PREX1 RYR3 | 1.18e-04 | 1285 | 90 | 12 | 35914814 | |
| Pubmed | 1.33e-04 | 300 | 90 | 6 | 28561026 | ||
| Pubmed | Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. | 1.38e-04 | 7 | 90 | 2 | 15107502 | |
| Pubmed | Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin. | 1.38e-04 | 7 | 90 | 2 | 8999968 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 12242670 | ||
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 8672144 | ||
| Pubmed | Different expression patterns of Phactr family members in normal and injured mouse brain. | 1.38e-04 | 7 | 90 | 2 | 22766235 | |
| Pubmed | Conformational switch of syntaxin-1 controls synaptic vesicle fusion. | 1.38e-04 | 7 | 90 | 2 | 18703708 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.49e-04 | 754 | 90 | 9 | 33060197 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.57e-04 | 195 | 90 | 5 | 17110338 | |
| Pubmed | 1.81e-04 | 201 | 90 | 5 | 34917906 | ||
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 1.84e-04 | 8 | 90 | 2 | 9382709 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 9756919 | ||
| Pubmed | A phenotype-based screen for embryonic lethal mutations in the mouse. | 1.84e-04 | 8 | 90 | 2 | 9636176 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 11533236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.84e-04 | 8 | 90 | 2 | 19033399 | |
| Pubmed | Comparative genome mapping in the sequence-based era: early experience with human chromosome 7. | 1.84e-04 | 8 | 90 | 2 | 10810084 | |
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 1.84e-04 | 8 | 90 | 2 | 2993224 | |
| Pubmed | 1.88e-04 | 320 | 90 | 6 | 28685749 | ||
| Pubmed | 1.94e-04 | 613 | 90 | 8 | 22268729 | ||
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 2.26e-04 | 331 | 90 | 6 | 19490893 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 2.32e-04 | 212 | 90 | 5 | 33462405 | |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 9819414 | ||
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 11956313 | ||
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 8838651 | ||
| Pubmed | Syntaxin isoform specificity in the regulation of renal H+-ATPase exocytosis. | 2.36e-04 | 9 | 90 | 2 | 12651853 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | IARS1 NAE1 DHX38 EIF3E NUDCD1 TUBGCP2 USP3 TNPO3 CCNA2 RGPD5 | 2.75e-04 | 1005 | 90 | 10 | 19615732 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.78e-04 | 344 | 90 | 6 | 36282215 | |
| Pubmed | Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47. | 2.83e-04 | 121 | 90 | 4 | 22354994 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 27466336 | ||
| Pubmed | Isl1 is upstream of sonic hedgehog in a pathway required for cardiac morphogenesis. | 2.94e-04 | 10 | 90 | 2 | 16687132 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 11983168 | ||
| Pubmed | CDK5RAP2 stimulates microtubule nucleation by the gamma-tubulin ring complex. | 2.94e-04 | 10 | 90 | 2 | 21135143 | |
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 3.38e-04 | 52 | 90 | 3 | 30389913 | |
| Pubmed | 3.38e-04 | 52 | 90 | 3 | 20114047 | ||
| Pubmed | 3.41e-04 | 504 | 90 | 7 | 34432599 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 25849387 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 20. | 3.97e-04 | 517 | 90 | 7 | 11780052 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 4.21e-04 | 56 | 90 | 3 | 9455484 | |
| Pubmed | Collagen XIV is important for growth and structural integrity of the myocardium. | 4.30e-04 | 12 | 90 | 2 | 22906538 | |
| Pubmed | 4.55e-04 | 878 | 90 | 9 | 37223481 | ||
| GeneFamily | Glycogen phosphorylases | 3.81e-05 | 3 | 65 | 2 | 437 | |
| GeneFamily | Phosphatase and actin regulators | 7.60e-05 | 4 | 65 | 2 | 679 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 5.62e-04 | 10 | 65 | 2 | 830 | |
| GeneFamily | UPF1 like RNA helicases | 6.85e-04 | 11 | 65 | 2 | 1169 | |
| GeneFamily | Syntaxins | 1.48e-03 | 16 | 65 | 2 | 818 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.09e-03 | 181 | 65 | 4 | 694 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 4.85e-03 | 29 | 65 | 2 | 754 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP | 5.74e-06 | 199 | 90 | 7 | M5446 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NCAPG SF3B3 TBC1D31 IARS1 NAE1 EIF3E UTP20 SOAT2 THOC5 CCNA2 CREB3L2 | 8.06e-06 | 612 | 90 | 11 | M4772 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | RGMB TMEM201 SF3B3 PDGFRB ARHGEF7 TM9SF4 PPP1R15B HELZ2 LAMB1 SOAT1 CREB3L2 | 2.17e-05 | 681 | 90 | 11 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | RGMB TMEM201 SF3B3 PDGFRB ARHGEF7 TM9SF4 PPP1R15B HELZ2 LAMB1 SOAT1 CREB3L2 | 2.91e-05 | 703 | 90 | 11 | MM1055 |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP | 5.07e-05 | 116 | 90 | 5 | M14146 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 6.33e-05 | 198 | 90 | 6 | M8274 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 6.51e-05 | 199 | 90 | 6 | M4607 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 6.69e-05 | 200 | 90 | 6 | M4622 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP | 6.69e-05 | 200 | 90 | 6 | M5723 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP | 6.69e-05 | 200 | 90 | 6 | M7424 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 9.98e-07 | 163 | 90 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.84e-06 | 181 | 90 | 6 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 2.15e-06 | 186 | 90 | 6 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-06 | 190 | 90 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.51e-06 | 191 | 90 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-06 | 198 | 90 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-06 | 198 | 90 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-06 | 199 | 90 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-06 | 199 | 90 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-06 | 199 | 90 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.39e-05 | 169 | 90 | 5 | 0ae65daf092396b71f790b65c7a2feed90397417 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.39e-05 | 169 | 90 | 5 | 8cd70ce27b1cecb83f8a376230e7ef41b079b124 | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.15e-05 | 179 | 90 | 5 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.15e-05 | 179 | 90 | 5 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.24e-05 | 180 | 90 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.50e-05 | 183 | 90 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 3.59e-05 | 184 | 90 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.69e-05 | 185 | 90 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 186 | 90 | 5 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 186 | 90 | 5 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.78e-05 | 186 | 90 | 5 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.78e-05 | 186 | 90 | 5 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.78e-05 | 186 | 90 | 5 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.78e-05 | 186 | 90 | 5 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-05 | 186 | 90 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 186 | 90 | 5 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.78e-05 | 186 | 90 | 5 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 3.78e-05 | 186 | 90 | 5 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 186 | 90 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 187 | 90 | 5 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 187 | 90 | 5 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.98e-05 | 188 | 90 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | bf77e59b9001c7f7ca17f81073f935f281a25a1f | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | b2472a294b25fc2f0da7f18519fdcb9ca166c6f0 | |
| ToppCell | COVID-19_Severe-pDC|World / disease group, cell group and cell class | 3.98e-05 | 188 | 90 | 5 | 4c8e328b8206120708b05ea3c5865a0200dc5c4e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-05 | 189 | 90 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.19e-05 | 190 | 90 | 5 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-05 | 190 | 90 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 190 | 90 | 5 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 4.19e-05 | 190 | 90 | 5 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 191 | 90 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 191 | 90 | 5 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.29e-05 | 191 | 90 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.29e-05 | 191 | 90 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | cb75e6c36dbe2e091e407d691c063ec7c4fd5f90 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.29e-05 | 191 | 90 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | b2cffea7860dd590b505ee0ebd51aa1978cb5e64 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.40e-05 | 192 | 90 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 192 | 90 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 4.40e-05 | 192 | 90 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.40e-05 | 192 | 90 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 192 | 90 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | e5117cdb8af220f60bd1410262078c0306667b4a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-05 | 193 | 90 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 4.51e-05 | 193 | 90 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-05 | 193 | 90 | 5 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-05 | 193 | 90 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 194 | 90 | 5 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 4.62e-05 | 194 | 90 | 5 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-05 | 194 | 90 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-05 | 194 | 90 | 5 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.62e-05 | 194 | 90 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 194 | 90 | 5 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 194 | 90 | 5 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.74e-05 | 195 | 90 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 196 | 90 | 5 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.97e-05 | 197 | 90 | 5 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 197 | 90 | 5 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 197 | 90 | 5 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 197 | 90 | 5 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.09e-05 | 198 | 90 | 5 | 08f9f05abad4e4078362ea8537c616084cb5d70a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 198 | 90 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 199 | 90 | 5 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 122 | 90 | 4 | c16110934172f174f4aefe14b81abce8514b30f0 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 122 | 90 | 4 | 006ac4f6807e688554d36557d29d5e5a0bc3c36f | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 122 | 90 | 4 | f3d9a5893fdee3562880fb6fc132b88169a7d997 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 128 | 90 | 4 | e100629f6038e32176ffcc81bd06bd175df46cef | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 2.25e-04 | 147 | 90 | 4 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-04 | 149 | 90 | 4 | 2624ad3926efc9f0f169daae263cef16861f132b | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.49e-04 | 151 | 90 | 4 | 527059e47e381b2f6d63c1abb39bc0795ee3829d | |
| ToppCell | Frontal_cortex-Endothelial-MURAL|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.49e-04 | 151 | 90 | 4 | 7570372a315bc312ff57bb5f483375c401ae8787 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 153 | 90 | 4 | 3724dd498b982be693ddff9cea7671863acf3ff8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 153 | 90 | 4 | d810fc5aff28449ce79b4148558b260878a2c696 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-04 | 155 | 90 | 4 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-04 | 155 | 90 | 4 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-04 | 155 | 90 | 4 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-04 | 155 | 90 | 4 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-04 | 156 | 90 | 4 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 157 | 90 | 4 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 158 | 90 | 4 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 158 | 90 | 4 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 158 | 90 | 4 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|normal_Lung / Location, Cell class and cell subclass | 3.03e-04 | 159 | 90 | 4 | f89fc18966d9b9b33e81e7b9eb3ec3420c20ff43 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-04 | 159 | 90 | 4 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| Drug | indirubin-5-sulphonate | 5.74e-07 | 5 | 89 | 3 | CID005288641 | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; HL60; HG-U133A | 1.08e-05 | 193 | 89 | 7 | 1773_DN | |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | 1.19e-05 | 196 | 89 | 7 | 7558_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.23e-05 | 197 | 89 | 7 | 6230_DN | |
| Drug | copper(II) sulfate pentahydrate; Up 200; 100uM; ssMCF7; HG-U133A | 1.28e-05 | 198 | 89 | 7 | 500_UP | |
| Drug | AC1Q6A3R | 1.51e-05 | 2 | 89 | 2 | CID000160583 | |
| Drug | gypsetin | 1.51e-05 | 2 | 89 | 2 | CID000160406 | |
| Drug | glisoprenin B | 1.51e-05 | 2 | 89 | 2 | CID006438769 | |
| Drug | NSC292654 | 1.51e-05 | 2 | 89 | 2 | CID000325064 | |
| Drug | 23-methyl-UDCA | 1.51e-05 | 2 | 89 | 2 | CID000196679 | |
| Drug | 7,7-difluorocholestanol | 1.51e-05 | 2 | 89 | 2 | CID000196646 | |
| Drug | 6,6-difluorocholestanol | 1.51e-05 | 2 | 89 | 2 | CID000196647 | |
| Drug | Aplus | 1.51e-05 | 2 | 89 | 2 | CID000028221 | |
| Drug | Ro 16-0521 | 1.51e-05 | 2 | 89 | 2 | CID000065657 | |
| Drug | AC1NT076 | 1.51e-05 | 2 | 89 | 2 | CID005321102 | |
| Drug | xymedon | 1.51e-05 | 2 | 89 | 2 | CID000121931 | |
| Drug | maslinic acid | 1.61e-05 | 13 | 89 | 3 | CID000073659 | |
| Drug | Gvapspat amide | 2.54e-05 | 15 | 89 | 3 | CID000125015 | |
| Drug | 2-hydroxyursolic acid | 4.52e-05 | 18 | 89 | 3 | CID000155934 | |
| Drug | 3,5-dimethylphenyl isocyanate | 4.52e-05 | 3 | 89 | 2 | CID000521488 | |
| Drug | glisoprenin A | 4.52e-05 | 3 | 89 | 2 | CID006438768 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 4.52e-05 | 3 | 89 | 2 | CID000147839 | |
| Drug | NSC758405 | 4.52e-05 | 3 | 89 | 2 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 4.52e-05 | 3 | 89 | 2 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 4.52e-05 | 3 | 89 | 2 | CID000196007 | |
| Drug | olean-12-ene | 4.52e-05 | 3 | 89 | 2 | CID000612780 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 4.52e-05 | 3 | 89 | 2 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 4.52e-05 | 3 | 89 | 2 | CID000191554 | |
| Drug | Purpactin A | 4.52e-05 | 3 | 89 | 2 | CID000131673 | |
| Drug | hydan | 4.52e-05 | 3 | 89 | 2 | CID000008360 | |
| Drug | EHMF | 4.52e-05 | 3 | 89 | 2 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 4.52e-05 | 3 | 89 | 2 | CID003082249 | |
| Drug | Plp 5'-mpa | 4.52e-05 | 3 | 89 | 2 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 4.52e-05 | 3 | 89 | 2 | CID000191723 | |
| Drug | 3'-FFdUrd | 4.52e-05 | 3 | 89 | 2 | CID000072260 | |
| Drug | Nsc692258 | 4.52e-05 | 3 | 89 | 2 | CID000469167 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 4.52e-05 | 3 | 89 | 2 | CID000119518 | |
| Drug | AC1L8XK3 | 4.52e-05 | 3 | 89 | 2 | CID000409735 | |
| Drug | ethyl 6-chlorochroman-2-carboxylate | 4.52e-05 | 3 | 89 | 2 | CID000169516 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 4.52e-05 | 3 | 89 | 2 | CID000446801 | |
| Drug | zaragozic acid D3 | 4.52e-05 | 3 | 89 | 2 | CID006475792 | |
| Drug | riboflavin tetraacetate | 4.52e-05 | 3 | 89 | 2 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 4.52e-05 | 3 | 89 | 2 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 4.52e-05 | 3 | 89 | 2 | CID000011459 | |
| Drug | galocitabine | 9.02e-05 | 4 | 89 | 2 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 9.02e-05 | 4 | 89 | 2 | CID000135786 | |
| Drug | Cgs-26214 | 9.02e-05 | 4 | 89 | 2 | CID000133077 | |
| Drug | ingliforib | 9.02e-05 | 4 | 89 | 2 | CID006451325 | |
| Drug | uric acid riboside | 9.02e-05 | 4 | 89 | 2 | CID000164933 | |
| Drug | isochromophilone VII | 9.02e-05 | 4 | 89 | 2 | CID006443571 | |
| Drug | isochromophilone VIII | 9.02e-05 | 4 | 89 | 2 | CID006443572 | |
| Drug | pseudo-dl-glucose | 9.02e-05 | 4 | 89 | 2 | CID000125259 | |
| Drug | pyridoxal diphosphate | 9.02e-05 | 4 | 89 | 2 | CID000125696 | |
| Drug | acaterin | 9.02e-05 | 4 | 89 | 2 | CID000126830 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 9.02e-05 | 4 | 89 | 2 | CID000189134 | |
| Drug | AC1LAMW2 | 9.02e-05 | 4 | 89 | 2 | CID000491364 | |
| Drug | FdUrd-C8 | 9.02e-05 | 4 | 89 | 2 | CID000094262 | |
| Drug | Mem-CC | 9.02e-05 | 4 | 89 | 2 | CID003081269 | |
| Drug | AC1L3QAA | 9.02e-05 | 4 | 89 | 2 | CID000093484 | |
| Drug | BCIp4A | 9.02e-05 | 4 | 89 | 2 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 9.02e-05 | 4 | 89 | 2 | CID000097703 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.63e-05 | 188 | 89 | 6 | 6451_DN | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 1.18e-04 | 195 | 89 | 6 | 667_DN | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 5819_UP | |
| Drug | heptulose-2-P | 1.50e-04 | 5 | 89 | 2 | CID000124823 | |
| Drug | 6-FPLP | 1.50e-04 | 5 | 89 | 2 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.50e-04 | 5 | 89 | 2 | CID009576855 | |
| Drug | DHPBU | 1.50e-04 | 5 | 89 | 2 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 1.50e-04 | 5 | 89 | 2 | CID003080910 | |
| Drug | AC1LCUXJ | 1.50e-04 | 5 | 89 | 2 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 1.50e-04 | 5 | 89 | 2 | CID000080578 | |
| Drug | etafenone | 1.50e-04 | 5 | 89 | 2 | CID000003275 | |
| Drug | ddEtUrd | 1.50e-04 | 5 | 89 | 2 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.50e-04 | 5 | 89 | 2 | CID000125618 | |
| Drug | NSC-110264 | 1.50e-04 | 5 | 89 | 2 | CID000269324 | |
| Drug | m-anisidine | 1.50e-04 | 5 | 89 | 2 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 1.50e-04 | 5 | 89 | 2 | CID000441028 | |
| Drug | 6-FDPL | 1.50e-04 | 5 | 89 | 2 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.50e-04 | 5 | 89 | 2 | CID003082179 | |
| Drug | GlcMan | 1.50e-04 | 5 | 89 | 2 | CID000152120 | |
| Drug | U66985 | 1.50e-04 | 5 | 89 | 2 | CID000127224 | |
| Drug | AC1O3M08 | 1.50e-04 | 5 | 89 | 2 | CID006331955 | |
| Drug | AC1L6KTW | 2.04e-04 | 74 | 89 | 4 | CID000247705 | |
| Drug | CV-araU | 2.24e-04 | 6 | 89 | 2 | CID006441877 | |
| Drug | 2-thiothymidine | 2.24e-04 | 6 | 89 | 2 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 2.24e-04 | 6 | 89 | 2 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 2.24e-04 | 6 | 89 | 2 | CID000152984 | |
| Drug | EdUMP | 2.24e-04 | 6 | 89 | 2 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 2.24e-04 | 6 | 89 | 2 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 2.24e-04 | 6 | 89 | 2 | CID000656428 | |
| Drug | AzddCyd | 2.24e-04 | 6 | 89 | 2 | CID000451374 | |
| Drug | 5-Ffdru | 2.24e-04 | 6 | 89 | 2 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 2.24e-04 | 6 | 89 | 2 | CID006439191 | |
| Drug | DNPP | 2.24e-04 | 6 | 89 | 2 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 2.24e-04 | 6 | 89 | 2 | CID000082693 | |
| Drug | NSC-97433 | 2.24e-04 | 6 | 89 | 2 | CID000001803 | |
| Drug | AR-L57 | 2.24e-04 | 6 | 89 | 2 | CID000156890 | |
| Drug | SCH 48461 | 2.24e-04 | 6 | 89 | 2 | CID000132832 | |
| Drug | hilE | 2.26e-04 | 76 | 89 | 4 | CID000000791 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 3.13e-04 | 7 | 89 | 2 | CID006439607 | |
| Disease | X-24020 measurement | 8.54e-05 | 5 | 87 | 2 | EFO_0022128 | |
| Disease | cholesteryl ester 24:4 measurement | 1.79e-04 | 7 | 87 | 2 | EFO_0021447 | |
| Disease | plasma trimethylamine N-oxide measurement | 3.81e-04 | 10 | 87 | 2 | EFO_0005691 | |
| Disease | cholesteryl ester 24:5 measurement | 5.56e-04 | 12 | 87 | 2 | EFO_0021448 | |
| Disease | basal cell carcinoma (is_implicated_in) | 5.56e-04 | 12 | 87 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | mean arterial pressure | 6.91e-04 | 499 | 87 | 7 | EFO_0006340 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 1.00e-03 | 16 | 87 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.03e-03 | 67 | 87 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | reticulocyte measurement | 1.07e-03 | 1053 | 87 | 10 | EFO_0010700 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.08e-03 | 152 | 87 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cervical artery dissection | 1.14e-03 | 17 | 87 | 2 | EFO_1000059 | |
| Disease | migraine disorder, systolic blood pressure | 1.28e-03 | 18 | 87 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | neonatal abstinence syndrome | 1.55e-03 | 77 | 87 | 3 | EFO_0005799 | |
| Disease | susceptibility to scarlet fever measurement | 1.67e-03 | 79 | 87 | 3 | EFO_0008409 | |
| Disease | systemising measurement | 1.74e-03 | 21 | 87 | 2 | EFO_0010221 | |
| Disease | blood pressure | 1.91e-03 | 22 | 87 | 2 | EFO_0004325 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.05e-03 | 181 | 87 | 4 | DOID:684 (is_implicated_in) | |
| Disease | arginine measurement | 2.09e-03 | 23 | 87 | 2 | EFO_0020990 | |
| Disease | Immunologic Deficiency Syndromes | 2.09e-03 | 23 | 87 | 2 | C0021051 | |
| Disease | Intellectual Disability | 2.10e-03 | 447 | 87 | 6 | C3714756 | |
| Disease | hypertension | 2.17e-03 | 307 | 87 | 5 | EFO_0000537 | |
| Disease | telomere length | 2.36e-03 | 313 | 87 | 5 | EFO_0004505 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.67e-03 | 26 | 87 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | migraine disorder, pulse pressure measurement | 2.67e-03 | 26 | 87 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | coronary artery disease | 2.69e-03 | 1194 | 87 | 10 | EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DMEDERDRDSYHSCH | 291 | Q9UPW8 | |
| LEEFDSMAHQDRHEF | 276 | Q9HCE0 | |
| SMAHQDRHEFYELLL | 281 | Q9HCE0 | |
| ISLHFIVFDTEMAHD | 1316 | Q96PZ7 | |
| RVISMDRDYHFECYH | 481 | Q96IF1 | |
| ATDDLDFRHHSYKDM | 556 | Q8IUX7 | |
| YNTLERVHMFEAHSD | 86 | P35606 | |
| MHLVFEYCDHTLLNE | 76 | Q5MAI5 | |
| HAVDRAIMEYHADAA | 216 | Q99758 | |
| LLKELERHMEDYHTD | 416 | Q14155 | |
| RMEEILHEHSYIAED | 241 | Q9H9F9 | |
| DEALKYLSRNHMHEE | 981 | Q93084 | |
| YHAHLDIEAFTMDRE | 291 | P00966 | |
| SDDHEMRNEVYHRKI | 186 | Q96DT6 | |
| HAVAFYVMDEDALSR | 66 | O43374 | |
| MDNYSHFHELRVTEE | 516 | Q9P0K7 | |
| HAVAFYVMDEDALSR | 66 | C9J798 | |
| YEEDAHITFAMLDAV | 646 | Q99666 | |
| FTMLLVHREARDEYH | 576 | Q14739 | |
| LRDDQYTLEHMHAFG | 46 | Q96RS6 | |
| YIHHFDRVIVMGAEA | 166 | Q86TA1 | |
| HQTYMEELRKLFEEH | 306 | Q96PD6 | |
| DMYHLSREGEAHECR | 156 | P43627 | |
| YTEMNEDSEIAFHLR | 41 | A8MUM7 | |
| MFDFLDEQADRHSIH | 1716 | O75051 | |
| EHMYHDLGLVRDFSI | 276 | O76083 | |
| TEYLHELAEAEERMA | 321 | P12525 | |
| DLEAEFHFTHLIMTF | 126 | P07942 | |
| HDPYSEFMVEEHELR | 401 | Q9BSJ2 | |
| HYEALRHFLLMEDGE | 1516 | Q96RT7 | |
| YEADDFEMAIRHFEQ | 221 | Q8IVL5 | |
| HYRLEDIAMAHHFRD | 341 | O75081 | |
| RYCLFMELLESSHHE | 2156 | A2RRP1 | |
| EMEVHEESKHFTRYH | 686 | Q8IZ21 | |
| HDMCRFHSEDYIDFL | 56 | O15379 | |
| EFVEHQIMHTRENLY | 466 | Q9GZU2 | |
| MDYFLDVESAHRLLD | 6 | Q9C0D0 | |
| IHFMETQYVDEHHFR | 461 | Q3MIT2 | |
| FGDEHMDEHLYVAFA | 406 | Q9BZJ0 | |
| DHSASKEDYMDRLEH | 326 | Q9H4Z3 | |
| DEYHVIRHAMNLEAV | 396 | Q92947 | |
| DEVIDFSHGLAMYER | 276 | Q6PCB6 | |
| MAEYDLTTRIAHFLD | 1 | P60228 | |
| LHEEHVELLMEEFAF | 121 | P53004 | |
| HSMDEFSHYDLLDAN | 296 | P28300 | |
| FDTRSEKYHHMETEE | 871 | O15021 | |
| PDYHEDIHTYLREME | 176 | P20248 | |
| LDRSLFERYHEDAHM | 2406 | Q9BYK8 | |
| DGEALMYHTHFSELL | 26 | Q70SY1 | |
| AGHYTMRAFHEDAEV | 391 | P09619 | |
| FHPIEEYMVHVEEHF | 376 | Q9BYC5 | |
| EYMVHVEEHFQLLAR | 381 | Q9BYC5 | |
| VRDLMHVHSFSYDFH | 3036 | Q5T011 | |
| RRYSDFHDFHMRITE | 611 | Q9Y5W8 | |
| LVQLTHYHDPEMDFF | 1561 | O75691 | |
| VERESGHYVEMHARY | 261 | Q6NW40 | |
| HHMDVYASSIDDILE | 281 | O95219 | |
| ELLEVDHIRTIYHMF | 131 | P35610 | |
| FEVESVTHHDYRMEL | 376 | Q99932 | |
| DAYRRKVDLEEHMFH | 851 | Q96DN5 | |
| RIAHDIFDHIYSMDE | 111 | O60282 | |
| IFDHIYSMDENLEFH | 116 | O60282 | |
| LEELQMEHDIRHYDL | 346 | Q9HCE1 | |
| VFHFHYEVDRRMSDT | 186 | Q9P212 | |
| RHLAEFYMIEAEISF | 251 | Q96I59 | |
| LLMVDHENFIYFHDR | 466 | O14975 | |
| IFDFLIGNMDRHHYE | 401 | Q96MK3 | |
| LYSEVDVHFRMIHED | 601 | Q7Z3K3 | |
| FMHHVLEKSEFRDES | 576 | Q8TCU6 | |
| EGHELHDEDIRLMYT | 936 | P41252 | |
| HDEDIRLMYTFDQAT | 941 | P41252 | |
| GYHSLEEEHSLLRMD | 321 | Q5SWA1 | |
| DHFMDDFFHQVEEIR | 26 | P32856 | |
| LDELMEVQHFRTIYH | 111 | O75908 | |
| HVIARHEYTFSIMDE | 66 | Q8WUH1 | |
| RTMDDKTVFHEEFIH | 36 | Q9BPX3 | |
| ILYYHREDMEEDQEH | 186 | Q92544 | |
| LMHHDRFKVFADYED | 766 | P11217 | |
| LELCEQEDLMRFHYH | 1546 | Q15413 | |
| VHVDRDHFMDEFFEQ | 21 | P61266 | |
| FHERHFHYEEHLERM | 46 | Q9H4X1 | |
| LMHHDRFKVFADYEA | 766 | P11216 | |
| EHASHGDREEIMRQY | 881 | Q96SB8 | |
| ADLDHYSAIIMDEAH | 641 | Q92620 | |
| YDEEVEVYRHHLEQM | 146 | Q5SNT2 | |
| EDHDFFQHVEMHLRS | 1136 | Q15393 | |
| LFTEAEHQDMHSYIA | 221 | Q99835 | |
| LETAYHMAVAREDLD | 276 | Q9Y5L0 | |
| AHEFMRYLLDHLHLE | 261 | Q9Y6I4 | |
| AHEDYMELHFTKDIV | 526 | Q13769 | |
| DEVETYFHEFGHVMH | 466 | P52888 | |
| ELREHFQSYDLDHME | 191 | Q13564 | |
| EKFMEHIITYHEFAE | 486 | Q92539 | |
| NHHYVELLGMSEDAR | 321 | Q86W24 |